Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Effects of β4 integrin expression on microRNA patterns in breast cancer.

Gerson KD, Maddula VS, Seligmann BE, Shearstone JR, Khan A, Mercurio AM.

Biol Open. 2012 Jul 15;1(7):658-66. doi: 10.1242/bio.20121628. Epub 2012 May 25.

2.

Integrin β4 regulates SPARC protein to promote invasion.

Gerson KD, Shearstone JR, Maddula VS, Seligmann BE, Mercurio AM.

J Biol Chem. 2012 Mar 23;287(13):9835-44. doi: 10.1074/jbc.M111.317727. Epub 2012 Feb 3.

3.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

4.

Computational prediction and experimental validation of evolutionarily conserved microRNA target genes in bilaterian animals.

Takane K, Fujishima K, Watanabe Y, Sato A, Saito N, Tomita M, Kanai A.

BMC Genomics. 2010 Feb 9;11:101. doi: 10.1186/1471-2164-11-101.

5.

MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.

Lee SE, Kim SJ, Youn JP, Hwang SY, Park CS, Park YS.

J Pineal Res. 2011 Oct;51(3):345-52. doi: 10.1111/j.1600-079X.2011.00896.x. Epub 2011 May 26.

PMID:
21615491
6.

Matrigel basement membrane matrix influences expression of microRNAs in cancer cell lines.

Price KJ, Tsykin A, Giles KM, Sladic RT, Epis MR, Ganss R, Goodall GJ, Leedman PJ.

Biochem Biophys Res Commun. 2012 Oct 19;427(2):343-8. doi: 10.1016/j.bbrc.2012.09.059. Epub 2012 Sep 18.

PMID:
23000157
7.

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, Tschulena U.

Oncogene. 2012 Sep 13;31(37):4150-63. doi: 10.1038/onc.2011.571. Epub 2011 Dec 12.

PMID:
22158050
8.

Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer.

Diaz LK, Cristofanilli M, Zhou X, Welch KL, Smith TL, Yang Y, Sneige N, Sahin AA, Gilcrease MZ.

Mod Pathol. 2005 Sep;18(9):1165-75.

9.

Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.

Xu X, Jia R, Zhou Y, Song X, Wang J, Qian G, Ge S, Fan X.

Int J Oncol. 2011 May;38(5):1385-93. doi: 10.3892/ijo.2011.961. Epub 2011 Mar 3.

PMID:
21373755
10.

miRNA expression patterns in chemoresistant breast cancer tissues.

Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.

Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5.

PMID:
25451164
11.

Dysregulated miR-183 inhibits migration in breast cancer cells.

Lowery AJ, Miller N, Dwyer RM, Kerin MJ.

BMC Cancer. 2010 Sep 21;10:502. doi: 10.1186/1471-2407-10-502.

12.

A miRNA signature of prion induced neurodegeneration.

Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA.

PLoS One. 2008;3(11):e3652. doi: 10.1371/journal.pone.0003652. Epub 2008 Nov 6.

13.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

14.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
15.

MicroRNA expression profiles in human colorectal cancers with liver metastases.

Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z, Shen X.

Oncol Rep. 2011 Mar;25(3):739-47. doi: 10.3892/or.2010.1112. Epub 2010 Dec 20.

PMID:
21174058
16.

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J.

PLoS One. 2009 Aug 18;4(8):e6677. doi: 10.1371/journal.pone.0006677.

17.

The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.

Takei Y, Takigahira M, Mihara K, Tarumi Y, Yanagihara K.

Cancer Res. 2011 Feb 15;71(4):1442-53. doi: 10.1158/0008-5472.CAN-10-2530. Epub 2010 Dec 17.

18.

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.

Rossing M, Borup R, Henao R, Winther O, Vikesaa J, Niazi O, Godballe C, Krogdahl A, Glud M, Hjort-Sørensen C, Kiss K, Bennedbæk FN, Nielsen FC.

J Mol Endocrinol. 2012 Jan 25;48(1):11-23. doi: 10.1530/JME-11-0039. Print 2012 Feb.

PMID:
22049245
19.

Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.

Kim HI, Huang H, Cheepala S, Huang S, Chung J.

Cancer Prev Res (Phila). 2008 Oct;1(5):385-91. doi: 10.1158/1940-6207.CAPR-08-0087.

20.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605

Supplemental Content

Support Center